Company / R&D per Share
CRESCENT BIOPHARMA, INC. R&D per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$135.56
FY2025
5-year range
$0.62 / $135.56
FY2021-FY2025
Trend
+12482.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +12482% YoY in FY2025, a notable deviation from the 4-year average annual change of +3116%.
Based on SEC 10-K filings.
135.56 in FY2025 with a 10-year CAGR of +71.4%.
Improved from $1.03 to $135.56 over the past 9 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +71.4%
Key checks
Key Insights
- CRESCENT BIOPHARMA, INC.'s r&d per share has grown for 3 consecutive years.
- In FY2025, r&d per share increased 12482.2% year-over-year.
- Lowest r&d per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $135.56 | +12482.2% |
| FY2017 | $1.08 | +4.9% |
| FY2016 | $1.03 | +66.3% |
| FY2015 | $0.62 | -90.7% |
| FY2014 | $6.62 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026